top of page


Take a look at the IAC-IAM 2027 Preliminary Agenda
Two conferences. Decades of discovery.
One extraordinary opportunity to shape what comes next.
IAC–IAM 2027 is expected to bring together 300 attendees from the international adrenal and aldosterone communities, including clinicians, basic and translational researchers, educators, early-career investigators, and pharmaceutical & biotechnology representatives advancing research and treatment across adrenal disorders.
Advancing the Next Generation of Adrenal Discovery
The IAC–IAM 2027 program connects Adrenal Biology & Development, Genomics & Emerging Technologies, Precision Therapeutics, and Clinical Translation & Patient Care, bringing research into how adrenal disease develops into conversation with advances in diagnosis, treatment and clinical decision-making.










bottom of page
.png)


























_edited_edited.png)